JASVINDER SINGH to Research Design
This is a "connection" page, showing publications JASVINDER SINGH has written about Research Design.
Connection Strength
0.574
-
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. 2018 Mar 27; 19(1):204.
Score: 0.090
-
Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking. Ann Rheum Dis. 2018 03; 77(3):317-318.
Score: 0.087
-
Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis. BMJ Open. 2016 09 20; 6(9):e012026.
Score: 0.081
-
Trial sample size, but not trial quality, is associated with positive study outcome. J Clin Epidemiol. 2010 Feb; 63(2):154-62.
Score: 0.050
-
Applying evidence-based methods to the development and use of adverse outcome pathways ALTEX. 2021; 38(2):336-347.
Score: 0.028
-
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study. Semin Arthritis Rheum. 2021 06; 51(3):601-606.
Score: 0.028
-
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 11; 161(11):2446-2461.
Score: 0.027
-
Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: a study protocol for an OMERACT initiative. BMJ Open. 2020 06 28; 10(6):e035207.
Score: 0.026
-
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review. J Rheumatol. 2020 10 01; 47(10):1565-1574.
Score: 0.025
-
Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements. J Rheumatol. 2018 03; 45(3):419-424.
Score: 0.022
-
GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process. J Clin Epidemiol. 2017 Oct; 90:84-91.
Score: 0.022
-
GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist. J Clin Epidemiol. 2017 Oct; 90:68-75.
Score: 0.021
-
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale. J Clin Epidemiol. 2017 Oct; 90:59-67.
Score: 0.021
-
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence. J Clin Epidemiol. 2017 Oct; 90:76-83.
Score: 0.021
-
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11.
Score: 0.012
-
Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum. 2007 Oct 15; 57(7):1119-33.
Score: 0.011